Q&A on the centralized rectification of corruption in the national pharmaceutical industry

2023-08-16

1、 What is the background and purpose of conducting centralized rectification work? Answer: The pharmaceutical field is the main battlefield for safeguarding the health of the people, and it is related to the most concerned, direct, and practical health rights and interests of the general public. The Party Central Committee attaches great importance to the high-quality development of the pharmaceutical industry and prioritizes the protection of people's health as a strategic priority for development. Since the 18th National Congress of the Communist Party of China, the pharmaceutical and healthcare industry has focused on major diseases and major issues that affect people's health, accelerated the implementation of the Healthy China strategy, promoted the sustained high-level development of pharmaceuticals, healthcare, and medical insurance, and promoted the expansion of high-quality medical resources and regional balanced layout. Medical workers shoulder the sacred responsibility of saving lives, helping injuries, and maintaining the health of the people. For a long time, medical personnel have responded to the call of the Communist Party of China and practiced the new era professional spirit of "respecting life, saving lives and injuries, willing to contribute, and loving the boundless". They have played an irreplaceable important role in disease prevention, diagnosis, treatment, rehabilitation, nursing, medical technology innovation and development, and achieved fruitful results, which have been understood, supported, and respected by the entire society. The hard work and dedication of medical workers should be fully recognized. Strengthening anti-corruption work in the pharmaceutical field is an important part of promoting high-quality development of the pharmaceutical industry and is an important component of improving the construction of the pharmaceutical governance system. For many years, the National Health Commission, as the leading unit of the inter-ministerial joint mechanism to correct unhealthy practices in the field of pharmaceutical purchasing and sales and medical services, has continuously strengthened the construction of industry style in conjunction with relevant departments. It has combined system construction, institutional construction, and the implementation of the nine principles of clean employment to resolutely rectify unhealthy practices in the industry and achieved significant improvements. Accompanied by historic achievements in comprehensive strict governance of the Party, the construction of Party conduct and clean governance, and the fight against corruption, the industry atmosphere in the pharmaceutical industry continues to improve. However, at the same time, corruption in the pharmaceutical industry still exists, especially in recent years when some "key minority" and key personnel in key positions have been investigated and punished for using their power to seek rent, recklessly accepting kickbacks, bribery, and other cases, which have seriously diluted the dividends of the reform and development of the pharmaceutical industry, encroached on the rights and interests of the people, hindered the reform and development of the medical, medical insurance, and pharmaceutical industries, and also affected the image of the industry, It also harms the interests of the vast majority of people in the field of medicine and health. In order to further promote the development and progress of the pharmaceutical industry and safeguard the health rights and interests of the people, the National Health Commission, together with nine departments including the Ministry of Education, the Ministry of Public Security, the National Audit Office, the State owned Assets Supervision and Administration Commission of the State Council, the State Administration for Market Regulation, the National Medical Insurance Bureau, the National Administration of Traditional Chinese Medicine, the National Bureau for Disease Control and Prevention, and the National Drug Administration, jointly launched a one-year centralized rectification work on corruption in the pharmaceutical field nationwide, with a problem oriented approach, Focusing on the "key minority" and key positions in the pharmaceutical industry, we will resolutely crack down on violations of regulations and laws, build a clean and upright industry atmosphere, and provide guarantees for the high-quality development of the pharmaceutical and health industry. 2、 What are the main principles for carrying out centralized rectification work this time? Answer: Currently, the difficulty of rectifying corruption in the pharmaceutical industry is increasing, and it is necessary for all departments involved in the entire pharmaceutical procurement and sales chain to strengthen their work collaboration and carry out joint governance. It is necessary to implement the concept of systematic governance throughout the work. Therefore, this centralized rectification work has clarified three working principles: first, comprehensive coverage and focus on key points. This rectification covers the production, circulation, and sales of the pharmaceutical industry

Edit:    Responsible editor:

Source:

Special statement: if the pictures and texts reproduced or quoted on this site infringe your legitimate rights and interests, please contact this site, and this site will correct and delete them in time. For copyright issues and website cooperation, please contact through outlook new era email:lwxsd@liaowanghn.com

Return to list

Recommended Reading Change it

Links

Submission mailbox:lwxsd@liaowanghn.com Tel:020-817896455

粤ICP备19140089号 Copyright © 2019 by www.lwxsd.com.all rights reserved

>